Intensive Blood Pressure Targets Cut Second-Stroke Risk in Survivors, OPTIMAL-Stroke Trial Finds

A Brazilian trial of more than 4,000 stroke and TIA survivors found that pushing systolic blood pressure below 120 mm Hg reduced major cardiovascular events by about 21% compared with the standard target of 140 mm Hg, strengthening the case for tighter blood pressure control after a stroke.

Chicago Metrowire Staff
••Healthcare
Intensive Blood Pressure Targets Cut Second-Stroke Risk in Survivors, OPTIMAL-Stroke Trial Finds

Survivors of an ischemic stroke or a transient ischemic attack (TIA) who received medication to drive systolic blood pressure below 120 mm Hg were significantly less likely to die or suffer a major cardiovascular event within four years than those treated to the conventional target of below 140 mm Hg, according to late-breaking science presented at the American Heart Association's Scientific Sessions 2026.

The finding matters because high blood pressure is the single most important modifiable risk factor for stroke, and roughly 185,000 recurrent strokes occur in the United States each year. Most of those repeat events are considered avoidable through lifestyle change and control of risk factors such as hypertension, poor diet, inactivity, smoking and obesity, according to the 2021 AHA/ASA Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack.

The OPTIMAL-Stroke trial, run at 30 health centers in Brazil, enrolled 4,368 adults between 2019 and 2022. Participants averaged 64 years of age, and their mean systolic pressure at enrollment was 146.7 mm Hg. They were randomly assigned to intensive treatment targeting below 120 mm Hg or standard treatment targeting below 140 mm Hg, and followed for an average of 3.9 years. Over the four-year intervention, major cardiovascular events occurred in 10.9% of the intensive group versus 13.5% of the standard group, a relative reduction of about 21%. Recurrent strokes fell to 4.7% from 6.4%, driven by fewer ischemic strokes. Serious adverse events were similar overall, though kidney-related events rose in the intensive arm.

"Our study shows that for many people who have already experienced an ischemic stroke or TIA, aiming for a systolic blood pressure below 120 mm Hg can provide additional cardiovascular protection compared with the conventional target of below 140 mm Hg," said principal investigator Gisele Sampaio, M.D., Ph.D., M.Sc., of the Federal University of São Paulo. She stressed that lower targets require medical supervision and monitoring of kidney function. Steering committee chair Otavio Berwanger, M.D., Ph.D., said controlling blood pressure after a stroke protects patients' lives and prevents further cardiovascular complications.

The results land alongside the AHA/ACC 2025 Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults, which recommends systolic pressure under 130 mm Hg and encourages readings below 120 mm Hg for people at increased cardiovascular risk. The trial was published simultaneously as a full manuscript in the New England Journal of Medicine, and its abstract appears in the 2026 Online Program Planner.

Limitations include that not every intensive-group patient reached the 120 mm Hg target, and the findings may not generalize beyond Brazil, where healthcare access and environmental factors differ. For patients, the practical message is captured in the association's guidance on Preventing Another Stroke and Understanding Blood Pressure Readings: know your numbers, take prescribed medications consistently and discuss an individual target with a care team.

Blockchain Registration

QR Code for Blockchain Registration